Age 30–59 with high lifetime risk, or a major risk enhancer (e.g. premature family history, South Asian ancestry) or elevated Lp(a)? No
risk-lowFewer than 5 people have reached this rule so farLifestyle is the treatment (see the meal & movement plan)
No clinician has signed off this rule yet. It reflects our reading of the guidelines cited below, which has not been independently checked.
Word for word, as generated for the example person below. Figures in the text are theirs.
Statin therapy is not routinely recommended at this risk level. Lifestyle is the treatment — see the meal and movement plan below.
Expert guidelinesOfficial guidelines recommend it, based on trials plus expert judgment.
Your estimated 10-year PREVENT ASCVD risk is 0.6%, below the 3% threshold where the guideline recommends considering statin therapy, and you have no risk-enhancing factors on record.
ACC/AHA (US)
The graded recommendation is health-behavior counseling at low risk. Not starting a statin follows from there being no graded recommendation to start one.
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Recommendation behind this rule · class and level read from the guideline tables on 2026-09-30
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Class 1 · Level A
“Low risk, nothing flagged” — an illustrative profile, not a real user.
Asked after: 10-year risk under 3%
Cited by the recommendations above.
For practising clinicians. Endorse it, propose a change, or dispute it. We verify every reviewer before a review is shown, and a review stays attached to the version of the rule you saw — if the rule changes, the page says so. You'll be asked to declare any relevant interests; they're shown with your review.
Log in or create an account to submit a review. An account is how we tie a review to a person we can verify.
Runs in lib/engine/lipidPathway.ts as risk-low.